Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Valeant Pharmaceuticals Intl Inc (VRX.TO)

Valeant Pharmaceuticals Intl Inc (VRX.TO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,758,416
  • Shares Outstanding, K 349,299
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta -1.49
  • Price/Sales N/A
  • Price/Cash Flow 4.64
  • Price/Book 1.85
Trade VRX.TO with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -2.64
  • Most Recent Earnings -7.68 on 03/31/18
  • Next Earnings Date 08/14/18
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend 1.000 on 11/10/10
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/18
See More
  • Average Estimate 1.04
  • Number of Estimates 6
  • High Estimate 1.19
  • Low Estimate 0.91
  • Prior Year 1.41
  • Growth Rate Est. (year over year) -26.24%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.80 +3.36%
on 07/06/18
35.73 -13.80%
on 06/15/18
-4.09 (-11.72%)
since 06/13/18
3-Month
21.10 +45.97%
on 04/16/18
36.02 -14.49%
on 06/13/18
+9.18 (+42.46%)
since 04/13/18
52-Week
14.01 +119.84%
on 11/02/17
36.02 -14.49%
on 06/13/18
+8.78 (+39.87%)
since 07/13/17

Most Recent Stories

More News
Primidone Market Global Market Size, Share, Growth, Demand ,Trends and Forecast,2021 -2028 By Ameco Research

pune, India, Tue, 31 Aug 2021 01:38:27 / Comserve Inc. / -- The global Primidone market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other

IPXL : 18.30 (unch)
VRX.TO : 30.80 (-3.33%)
Topical Drug Delivery Market Report 2021: The Market is Shifting Toward Quality, Safety, and Efficacious Products – Forecast to 2028

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include GlaxoSmithKline...

BAYRY : 13.2900 (-1.41%)
CRRTF : 0.5546 (-0.22%)
NVS : 83.48 (-1.07%)
VRX.TO : 30.80 (-3.33%)
Global Musculoskeletal Medicine Market SWOT Analysis,Key Indicators,Forecast 2027 : Mylan N.V., Dr. Reddy`s Laboratories Ltd.

ACOR : 4.73 (+0.85%)
HKMPF : 34.2500 (-0.15%)
MRK : 71.68 (-0.40%)
NVS : 83.48 (-1.07%)
TEVA : 8.99 (+0.45%)
VRX.TO : 30.80 (-3.33%)
Specialty Generic Drugs Market Size 2021, Industry outlook, Share Estimation, Trend Analysis, Company Profiles with Strategies, Production-Scenario and Supply Forecast 2030

In a recent published report, Kenneth Research has updated the market report for Specialty Generic Drugs Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or...

ENDP : 2.83 (+4.04%)
NVS : 83.48 (-1.07%)
PFE : 43.89 (-1.30%)
VRX.TO : 30.80 (-3.33%)
Cataract Surgery Devices Market Research Report with Size, Share, Value, CAGR, Outlook, Analysis, Latest Updates, Data, and News 2021-2027.

The global Cataract Surgery Devices market is expected to grow at a CAGR of 4.4% during the forecast period.The global Cataract Surgery Devices market is estimated to be about 6331.2 million US dollars...

ABT : 126.79 (-0.51%)
AGN : 193.02 (+0.02%)
CZMWF : 220.8323 (+17.31%)
GKOS : 53.94 (+2.10%)
NVS : 83.48 (-1.07%)
STAA : 143.37 (-0.55%)
TOPCF : 18.2350 (+1.35%)
VRX.TO : 30.80 (-3.33%)
Antiepileptic Drugs Market Size & Share, Future Growth, Trends Evaluation, Demands, Regional Analysis and Forecast to 2030

In a recent published report, Kenneth Research has updated the market report for Antiepileptic Drugs Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being...

ABT : 126.79 (-0.51%)
GSK : 38.93 (-0.46%)
NVS : 83.48 (-1.07%)
PFE : 43.89 (-1.30%)
VRX.TO : 30.80 (-3.33%)
Atopic Dermatitis Market Growth Drivers, Opportunities, Trends, and Forecasts to 2023

AGN : 193.02 (+0.02%)
ANAC : 9.77 (+0.10%)
ALPMF : 17.2500 (+0.88%)
BMY : 61.31 (+0.13%)
NVS : 83.48 (-1.07%)
PFE : 43.89 (-1.30%)
REGN : 651.88 (-0.20%)
VRX.TO : 30.80 (-3.33%)
Eye Care Surgical Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025

Japan, Japan, Tue, 24 Aug 2021 08:01:21 / Comserve Inc. / -- The report predicts the global eye care surgical market to grow at a healthy CAGR over the forecast period from 2019-2025.

CZMWF : 220.8323 (+17.31%)
NVS : 83.48 (-1.07%)
VRX.TO : 30.80 (-3.33%)
Respiratory Syncytial Virus (RSV) Therapeutics Market Size, Share, Trends, Analysis and Forecast 2027

The Global is estimated to value over USD 2.4 billion by 2027 end at a CAGR of over 11.7% during the forecast period 2020 to 2027.

ABBV : 107.73 (-0.32%)
AZN : 55.56 (-1.84%)
GILD : 71.61 (+0.39%)
GSK : 38.93 (-0.46%)
MRK : 71.68 (-0.40%)
VRX.TO : 30.80 (-3.33%)
Asia-Pacific Eyewear Market Future Demand And Leading Players Updates By Forecast To 2021

According to the report published by Allied Market Research, The Asia-Pacific Eyewear Market by Product Type, by Mode of Sale and End User: Opportunity Analysis and Industry Forecast, 2014 to 2021. In-depth...

HOCPF : 168.7500 (-3.16%)
VRX.TO : 30.80 (-3.33%)

Key Turning Points

3rd Resistance Point N/A
2nd Resistance Point 32.69
1st Resistance Point 31.74
Last Price 30.80
1st Support Level 30.30
2nd Support Level 29.81
3rd Support Level N/A

See More

52-Week High 36.02
Last Price 30.80
Fibonacci 61.8% 27.61
Fibonacci 50% 25.01
Fibonacci 38.2% 22.42
52-Week Low 14.01

See More

Business Summary

Valeant Pharmaceuticals International Inc is a specialty pharmaceutical and medical device company which develops, manufactures, and markets a range of generic and branded generic pharmaceuticals, over-the-counter products and medical devices.

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar